Quarterly compliance certificate to depositories for September quarter

Compliance View source PDF Explain this filing

MADHAVBAUG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.4%Reaction day

₹170.50

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-2.1% vs market

On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-1.4+0.7-2.1

Next day

-1.5-1.0-0.5

-5.5-0.3-5.3

-8.1-1.9-6.2

-12.6-4.5-8.1

-14.1-5.5-8.7

—-7.3—

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vaidya Sane Ayurved Laboratories filed a routine compliance certificate with NSE and the depositories for the quarter ended 30 September 2026. The Registrar and Transfer Agent, Bigshare Services, confirmed that all company shares are already held in demat form and no rematerialisation requests were received from any shareholder during the quarter. This is a standard regulatory submission under Regulation 74(5) of SEBI Depositories Regulations 2018.

Likely market impact

Routine regulatory compliance filing with no material impact on shareholders or stock price.